Yahoo! Finance: Biotechnology Industry News: CVac(TM) CAN-003 Trial Selected for Oral Presentation at the European Cancer Congress

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

CVac(TM) CAN-003 Trial Selected for Oral Presentation at the European Cancer Congress Jun 19th 2013, 23:05 [Marketwired] - Prima BioMed Ltd today announced that the abstract titled "Clinical study of autologous dendritic cell therapy targeting mucin 1 for treatment of ovarian cancer patients in first remission" has ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions